CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-30 | LEVIN ALAN G Director | Purchase | +7,861 | $6.36 | $50K | 44,951 |
| 2024-05-24 | ASELAGE STEVE Director | Purchase | +2,500 | $6.40 | $16K | 2,500 |
| 2024-05-20 | Hutson Nancy J Director | Purchase | +5,000 | $6.38 | $32K | 86,818 |
| 2024-05-20 | MILANO VINCENT Director | Purchase | +15,000 | $6.25 | $94K | 66,997 |
| 2024-05-14 | Doyle Anthony Chief Financial Officer | Purchase | +36,300 | $5.57 | $202K | 266,744 |
| 2024-05-14 | Thackray Helen M. Chief R&D Officer | Purchase | +30,000 | $5.86 | $176K | 272,139 |
| 2024-05-13 | Galson Steven K Director | Purchase | +21,940 | $5.49 | $120K | 51,551 |
| 2024-05-13 | Barnes Alane P Chief Legal Officer | Purchase | +5,000 | $5.53 | $28K | 300,762 |
| 2024-05-13 | Stonehouse Jon P President & CEO | Purchase | +30,000 | $5.55 | $167K | 1,127,770 |
| 2024-05-13 | Gayer Charles K Chief Commercial Officer | Purchase | +30,000 | $5.47 | $164K | 307,533 |
Page 1 of 1 · 10 trades